Research history is not product proof
A long timeline and a large paper count show scientific interest. They do not mean that every proposed use works, or that every hydrogen device has been clinically validated.
Hydrogen is the simplest molecule, but its modern medical-research story did not begin as a consumer wellness trend. Researchers first encountered it in specialised physiological and diving contexts before examining possible biological effects in laboratory models.
Before 2007: physiology and deep diving
Hydrogen-containing breathing mixtures were investigated for very deep diving because gas density becomes a major problem under pressure. These unusual environments provided observations about human exposure, but they were not evidence for today’s wellness uses and should not be presented as such.
2007: a modern turning point
The field changed when Ohsawa and colleagues published a paper in Nature Medicine proposing that molecular hydrogen could affect selected highly reactive oxygen species. The study combined chemistry, cells and a rat model of cerebral ischaemia-reperfusion injury.
Its significance was not that a disease treatment had been proven. It supplied a testable biological hypothesis and helped make molecular hydrogen a serious subject for wider investigation.
2007 onward: rapid preclinical expansion
Researchers explored hydrogen gas, hydrogen-rich water and hydrogen-rich saline across many cell and animal models. A 2015 review counted 321 original articles through June of that year and reported that roughly three-quarters involved mice or rats. That distinction matters: preclinical evidence helps form hypotheses but often does not translate directly into useful human treatment.
Human research grows—but remains varied
Human studies now cover different populations, delivery methods and outcomes. Some are small pilot studies; others use randomised or controlled designs. They should not be blended into one universal claim because inhaled gas, dissolved hydrogen in water, dose, duration and participant condition are not interchangeable.
Systematic evaluation should look beyond whether a result was called positive. Study registration, sample size, control group, blinding, predefined outcomes, effect size, replication and safety reporting all influence how much confidence a result deserves.
Where the field stands
Molecular hydrogen remains an active research area rather than a universal established therapy. Proposed actions include direct chemical reactions and effects on redox, inflammatory and cell-signalling pathways, but the exact targets and clinical relevance are not fully resolved.
Velta’s role is to explain the technology accurately, distinguish inhalation from hydrogen-rich water, document exact product operation and avoid turning developing research into a promise to prevent or cure disease.
Research timeline
Sources
- Li H, et al. Trend of research on the medical use of molecular hydrogen: a bibliometric analysis. Medical Gas Research. 2023.
- Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007.
- Ichihara M, et al. Comprehensive review of 321 original molecular-hydrogen articles through June 2015.
- Molecular Hydrogen Therapy—A Review on Clinical Studies and Outcomes. 2023.